Health Care & Hospital Law
May 18, 2011
Eli Lilly Faces Drug Marketing Suit
Amylin Pharmaceuticals Inc. filed a sealed lawsuit against Eli Lilly and Co. on Monday claiming the company engaged in anti-competitive activity and breached a strategic alliance by marketing a competitor's diabetes drug.
Daily Journal Staff Writer
San Diego-based Amylin Pharmaceuticals Inc. filed a sealed lawsuit against prescription drug giant Eli Lilly and Co. in federal court on Monday claiming the company engaged in anti-competitive activity and breached a strategic alliance by marketing a competitor's diabetes drug.
Amylin and Lilly signed an agreement in 2002 in which Lilly is responsible for marketing Amylin's drugs. Amyl...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In